Definium Therapeutics, Inc. DFTX
At closeNov 13, 2026, 4:00 PM EST
After hours · Nov 13, 4:00 PM ET
- YTD
- +139.58%
- 1 year
- +175.84%
DFTX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-131,560,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -131,560,000 | -52,431,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -79,129,000 | -14,764,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -64,365,000 | -14,226,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -50,139,000 | -4,315,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -45,824,000 | -22,227,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -23,597,000 | -20,398,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -3,199,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.